MAP Pharmaceuticals Stock Price, News & Analysis (NASDAQ:MAPP)

Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About MAP Pharmaceuticals (NASDAQ:MAPP)

MAP Pharmaceuticals logoMAP Pharmaceuticals, Inc., incorporated on July 3, 2003, is a development-stage company. As of December 31, 2011, the Company was focusing to advance its product candidate, LEVADEX (MAP0004) orally inhaled migraine therapy, which is an orally inhaled version of dihydroergotamine mesylate (DHE), for the acute treatment of migraine. The Company had completed clinical development for LEVADEX in 2011 and submitted its New Drug Application (NDA) to the United States Food and Drug Administration (FDA). LEVADEX is at-home therapy in development that patients self-administer using its hand-held TEMPO inhaler. Effective March 1, 2013, Allergen Inc acquired the entire share capital of MAP Pharmaceuticals Inc.

Receive MAPP News and Ratings via Email

Sign-up to receive the latest news and ratings for MAPP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:MAPP
CUSIPN/A
WebN/A
Phone+1-302-6587581

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

MAP Pharmaceuticals (NASDAQ:MAPP) Frequently Asked Questions

What is MAP Pharmaceuticals' stock symbol?

MAP Pharmaceuticals trades on the NASDAQ under the ticker symbol "MAPP."

Who are some of MAP Pharmaceuticals' key competitors?

How do I buy MAP Pharmaceuticals stock?

Shares of MAP Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact MAP Pharmaceuticals?

MAP Pharmaceuticals' mailing address is 2525 Dupont Dr, IRVINE, CA 92612-1531, United States. The healthcare company can be reached via phone at +1-302-6587581.


MarketBeat Community Rating for MAP Pharmaceuticals (MAPP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  48 (Vote Underperform)
Total Votes:  111
MarketBeat's community ratings are surveys of what our community members think about MAP Pharmaceuticals and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MAP Pharmaceuticals (NASDAQ:MAPP) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for MAP Pharmaceuticals (NASDAQ:MAPP)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

MAP Pharmaceuticals (NASDAQ:MAPP) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for MAP Pharmaceuticals (NASDAQ:MAPP)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for MAP Pharmaceuticals (NASDAQ MAPP)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

MAP Pharmaceuticals (NASDAQ MAPP) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

MAP Pharmaceuticals (NASDAQ:MAPP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

MAP Pharmaceuticals (NASDAQ:MAPP) Income Statement, Balance Sheet and Cash Flow Statement

Chart

MAP Pharmaceuticals (NASDAQ MAPP) Stock Chart for Tuesday, December, 12, 2017

Loading chart…

This page was last updated on 12/12/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.